In this presentation, you'll learn:
- Impact of PD on daily life: Understand how PD affects a person's occupational performance and quality of life through the WHO's ICF (International Classification of Functioning, Disability, and Health) model.
- Current practice gaps in OT for PD: identify areas where occupational therapy management for PD can be improved based on current research.
- Comprehensive OT interventions: Discover evidence-based occupational therapy approaches for managing PD symptoms, including "what," "when," and "how" to implement them.
- Formulating PD rehab services: Gain insights on developing comprehensive PD rehabilitation programs tailored to your specific context.
- Extensive references: Access a complete list of references cited in the presentation for further exploration.
Parkinson's disease is a progressive nervous system disorder that causes tremors, decreased muscle movement, and impaired balance. It occurs when dopamine-generating cells in the brain die, causing low dopamine levels. While the exact cause is unknown, genetic and environmental factors may play a role. Symptoms typically begin on one side of the body and include tremors, slowed movement, muscle stiffness, balance issues, and loss of automatic movements. Diagnosis is based on medical history, symptoms, and tests to rule out other conditions. There is no cure, but treatments aim to reduce symptoms and may include medication, deep brain stimulation surgery, exercise, and healthy eating. Managing the condition requires finding the right doctors, medication management, physical therapy,
Parkinson’s Disease is the second most common progressive neurodegenerative disorder affecting older American adults and is predicted to increase in prevalence as the United States population ages. Resulting from a pathophysiologic loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain and the development of neuronal Lewy Bodies, idiopathic Parkinson’s Disease is associated with risk factors including aging, family history, pesticide exposure and environmental chemicals (e.g., synthetic heroin use). Its ultimate cause(s) is (are) unknown. Characterized by both motor and non-motor symptoms, PD patients classically display rest tremor, rigidity, bradykinesia, and stooping posture. PD can also be associated with neurobehavioral disorders (depression, anxiety), cognitive impairment (dementia), and autonomic dysfunction (e.g., orthostasis and hyperhidrosis). Recent decades have witnessed a proliferation of medical pharmacologic therapies and innovative surgical interventions like deep brain stimulation (DBS). However, definitive disease-modifying therapy is still lacking. Experimental therapies are being developed and tested with limited results. Knowledge of strategies to promote optimal quality of life for PD patients is of paramount importance for caregivers, health providers and patients themselves.
Parkinson's disease is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. The document defines Parkinson's disease and discusses its epidemiology, types, symptoms, risk factors, complications, diagnosis, evaluation scales, management including pharmacological and non-pharmacological approaches, and patient counselling points. The disease is caused by degeneration of dopaminergic neurons and impacts mobility through motor symptoms like tremors, rigidity, and postural instability. It is generally diagnosed clinically and may be supported by imaging or neurological tests. Management focuses on symptom control through medications and lifestyle modifications.
Parkinson's disease is a progressive neurodegenerative disorder that causes motor impairment due to the loss of dopaminergic neurons. The main symptoms are tremors, muscular rigidity, and slow, imprecise movements. It occurs due to the death of dopamine-producing brain cells, leading to imbalances in neurotransmitters. While there is no cure, treatments can provide relief from symptoms and slow progression through medications, surgery, therapy, and lifestyle management.
Submission Ide 88c19114-7d71-4703-b679-22f6c2ee580479 SI.docxdeanmtaylor1545
Submission Ide: 88c19114-7d71-4703-b679-22f6c2ee5804
79% SIMILARITY SCORE 4 CITATION ITEMS 66 GRAMMAR ISSUES 0 FEEDBACK COMMENT
Internet Source 79%
Institution 0%
Muhammad Aftkhar
Parkinsonism- Pharmaceutical Treatment Plan.docx
Summary
1140 Words
1
Running Header: PARKINSON'S DISEASE
2
PARKINSON'S DISEASE
Parkinson’s disease
Parkinson's disease is a neuro de-generative disease that occurs and depletes the neurons
present in substansia nigra. These neurons are involved in the transmission of nerve impulses
Web Content: https://mynursingexperts.com/checking-and-assignment-corection/…
Spelling mistake: neuro euro
Spelling mista...: de-generative degenerative
PARKINSON'S DISEASE
MUHAMMAD AFTKHAR
NUR 635 (GCU)
Mar 4th, 2020
https://www.researchgate.net/profile/Charles_Davie/publication/5454757_A_review_of_Parkinson's_disease/links/5866522a08ae8fce490ee2e6/A-review-of-Parkinsons-disease.pdf
https://www.researchgate.net/profile/Charles_Davie/publication/5454757_A_review_of_Parkinson's_disease/links/5866522a08ae8fce490ee2e6/A-review-of-Parkinsons-disease.pdf
https://www.sciencedirect.com/science/article/abs/pii/S1474442218302394
https://www.sciencedirect.com/science/article/abs/pii/S1043661818321078
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140171/
from corpus collosum to the susbtansia nigra part of the mid brain. These are the character
playing neurons in managing voluntary motor movements in the body. It mostly occurs in elderly
patients describe by involuntary movements and multi-dimensional brain functioning. The part
of this disease may occur due to the effective and excessive use of medications indulging in bi
polar or Alzheimer's disease (Davie, 2008). The decline of dopamine in par compacta
deteriorates the normal functioning of the brain in controlling motor activities.
Prescription medication
The prescribed medications used for Parkinson’s disease includes the use of Levodopa
directly with replenishes the pool for dopamine neurotransmitter. This drug can’t be given in a
single dose rather without carbidopa (LODOSYN) the levodopa will break down into dopamine
and then to epinephrine in the body’s periphery. This will create severe symptomatic side effects
like an increase in heart rate and sympathetic system dominancy. Dopa-decarboxylase enzyme
breaks down the levodopa in the periphery so along with levodopa carbidopa is given. This
inhibits the dopa-decarboxylase enzyme and allows levodopa to travel into the blood brain
barrier easily.
For the calculations of drug regimen there must be precautionary measures for kidney
and liver sensitive enzyme dependent patients. LFT and RFT’s for sensitive patients are done to
ensure the correct for dose adjustments not lying in range affecting kidneys and liver function.
Below are some of the medications for Parkinson’s d.
Parkinson's disease is a progressive nervous system disorder that causes tremors, decreased muscle movement, and impaired balance. It occurs when dopamine-generating cells in the brain die, causing low dopamine levels. While the exact cause is unknown, genetic and environmental factors may play a role. Symptoms typically begin on one side of the body and include tremors, slowed movement, muscle stiffness, balance issues, and loss of automatic movements. Diagnosis is based on medical history, symptoms, and tests to rule out other conditions. There is no cure, but treatments aim to reduce symptoms and may include medication, deep brain stimulation surgery, exercise, and healthy eating. Managing the condition requires finding the right doctors, medication management, physical therapy,
Parkinson’s Disease is the second most common progressive neurodegenerative disorder affecting older American adults and is predicted to increase in prevalence as the United States population ages. Resulting from a pathophysiologic loss or degeneration of dopaminergic neurons in the substantia nigra of the midbrain and the development of neuronal Lewy Bodies, idiopathic Parkinson’s Disease is associated with risk factors including aging, family history, pesticide exposure and environmental chemicals (e.g., synthetic heroin use). Its ultimate cause(s) is (are) unknown. Characterized by both motor and non-motor symptoms, PD patients classically display rest tremor, rigidity, bradykinesia, and stooping posture. PD can also be associated with neurobehavioral disorders (depression, anxiety), cognitive impairment (dementia), and autonomic dysfunction (e.g., orthostasis and hyperhidrosis). Recent decades have witnessed a proliferation of medical pharmacologic therapies and innovative surgical interventions like deep brain stimulation (DBS). However, definitive disease-modifying therapy is still lacking. Experimental therapies are being developed and tested with limited results. Knowledge of strategies to promote optimal quality of life for PD patients is of paramount importance for caregivers, health providers and patients themselves.
Parkinson's disease is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. The document defines Parkinson's disease and discusses its epidemiology, types, symptoms, risk factors, complications, diagnosis, evaluation scales, management including pharmacological and non-pharmacological approaches, and patient counselling points. The disease is caused by degeneration of dopaminergic neurons and impacts mobility through motor symptoms like tremors, rigidity, and postural instability. It is generally diagnosed clinically and may be supported by imaging or neurological tests. Management focuses on symptom control through medications and lifestyle modifications.
Parkinson's disease is a progressive neurodegenerative disorder that causes motor impairment due to the loss of dopaminergic neurons. The main symptoms are tremors, muscular rigidity, and slow, imprecise movements. It occurs due to the death of dopamine-producing brain cells, leading to imbalances in neurotransmitters. While there is no cure, treatments can provide relief from symptoms and slow progression through medications, surgery, therapy, and lifestyle management.
Submission Ide 88c19114-7d71-4703-b679-22f6c2ee580479 SI.docxdeanmtaylor1545
Submission Ide: 88c19114-7d71-4703-b679-22f6c2ee5804
79% SIMILARITY SCORE 4 CITATION ITEMS 66 GRAMMAR ISSUES 0 FEEDBACK COMMENT
Internet Source 79%
Institution 0%
Muhammad Aftkhar
Parkinsonism- Pharmaceutical Treatment Plan.docx
Summary
1140 Words
1
Running Header: PARKINSON'S DISEASE
2
PARKINSON'S DISEASE
Parkinson’s disease
Parkinson's disease is a neuro de-generative disease that occurs and depletes the neurons
present in substansia nigra. These neurons are involved in the transmission of nerve impulses
Web Content: https://mynursingexperts.com/checking-and-assignment-corection/…
Spelling mistake: neuro euro
Spelling mista...: de-generative degenerative
PARKINSON'S DISEASE
MUHAMMAD AFTKHAR
NUR 635 (GCU)
Mar 4th, 2020
https://www.researchgate.net/profile/Charles_Davie/publication/5454757_A_review_of_Parkinson's_disease/links/5866522a08ae8fce490ee2e6/A-review-of-Parkinsons-disease.pdf
https://www.researchgate.net/profile/Charles_Davie/publication/5454757_A_review_of_Parkinson's_disease/links/5866522a08ae8fce490ee2e6/A-review-of-Parkinsons-disease.pdf
https://www.sciencedirect.com/science/article/abs/pii/S1474442218302394
https://www.sciencedirect.com/science/article/abs/pii/S1043661818321078
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140171/
from corpus collosum to the susbtansia nigra part of the mid brain. These are the character
playing neurons in managing voluntary motor movements in the body. It mostly occurs in elderly
patients describe by involuntary movements and multi-dimensional brain functioning. The part
of this disease may occur due to the effective and excessive use of medications indulging in bi
polar or Alzheimer's disease (Davie, 2008). The decline of dopamine in par compacta
deteriorates the normal functioning of the brain in controlling motor activities.
Prescription medication
The prescribed medications used for Parkinson’s disease includes the use of Levodopa
directly with replenishes the pool for dopamine neurotransmitter. This drug can’t be given in a
single dose rather without carbidopa (LODOSYN) the levodopa will break down into dopamine
and then to epinephrine in the body’s periphery. This will create severe symptomatic side effects
like an increase in heart rate and sympathetic system dominancy. Dopa-decarboxylase enzyme
breaks down the levodopa in the periphery so along with levodopa carbidopa is given. This
inhibits the dopa-decarboxylase enzyme and allows levodopa to travel into the blood brain
barrier easily.
For the calculations of drug regimen there must be precautionary measures for kidney
and liver sensitive enzyme dependent patients. LFT and RFT’s for sensitive patients are done to
ensure the correct for dose adjustments not lying in range affecting kidneys and liver function.
Below are some of the medications for Parkinson’s d.
Submission Ide 88c19114-7d71-4703-b679-22f6c2ee580479 SI.docxdavid4611
Submission Ide: 88c19114-7d71-4703-b679-22f6c2ee5804
79% SIMILARITY SCORE 4 CITATION ITEMS 66 GRAMMAR ISSUES 0 FEEDBACK COMMENT
Internet Source 79%
Institution 0%
Muhammad Aftkhar
Parkinsonism- Pharmaceutical Treatment Plan.docx
Summary
1140 Words
1
Running Header: PARKINSON'S DISEASE
2
PARKINSON'S DISEASE
Parkinson’s disease
Parkinson's disease is a neuro de-generative disease that occurs and depletes the neurons
present in substansia nigra. These neurons are involved in the transmission of nerve impulses
Web Content: https://mynursingexperts.com/checking-and-assignment-corection/…
Spelling mistake: neuro euro
Spelling mista...: de-generative degenerative
PARKINSON'S DISEASE
MUHAMMAD AFTKHAR
NUR 635 (GCU)
Mar 4th, 2020
https://www.researchgate.net/profile/Charles_Davie/publication/5454757_A_review_of_Parkinson's_disease/links/5866522a08ae8fce490ee2e6/A-review-of-Parkinsons-disease.pdf
https://www.researchgate.net/profile/Charles_Davie/publication/5454757_A_review_of_Parkinson's_disease/links/5866522a08ae8fce490ee2e6/A-review-of-Parkinsons-disease.pdf
https://www.sciencedirect.com/science/article/abs/pii/S1474442218302394
https://www.sciencedirect.com/science/article/abs/pii/S1043661818321078
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140171/
from corpus collosum to the susbtansia nigra part of the mid brain. These are the character
playing neurons in managing voluntary motor movements in the body. It mostly occurs in elderly
patients describe by involuntary movements and multi-dimensional brain functioning. The part
of this disease may occur due to the effective and excessive use of medications indulging in bi
polar or Alzheimer's disease (Davie, 2008). The decline of dopamine in par compacta
deteriorates the normal functioning of the brain in controlling motor activities.
Prescription medication
The prescribed medications used for Parkinson’s disease includes the use of Levodopa
directly with replenishes the pool for dopamine neurotransmitter. This drug can’t be given in a
single dose rather without carbidopa (LODOSYN) the levodopa will break down into dopamine
and then to epinephrine in the body’s periphery. This will create severe symptomatic side effects
like an increase in heart rate and sympathetic system dominancy. Dopa-decarboxylase enzyme
breaks down the levodopa in the periphery so along with levodopa carbidopa is given. This
inhibits the dopa-decarboxylase enzyme and allows levodopa to travel into the blood brain
barrier easily.
For the calculations of drug regimen there must be precautionary measures for kidney
and liver sensitive enzyme dependent patients. LFT and RFT’s for sensitive patients are done to
ensure the correct for dose adjustments not lying in range affecting kidneys and liver function.
Below are some of the medications for Parkinson’s d.
This document proposes a randomized controlled study to investigate the effects of bright light therapy on sleep and mood disorders in Parkinson's disease. 80 Parkinson's patients will be included and randomized to either real or placebo light therapy groups. Primary outcomes will be mood measures, and sleep parameters, motor symptoms, physiological markers, and biological rhythms will also be assessed if additional funding is obtained. The goal is to develop an effective non-pharmacological therapy to improve sleep, mood, and quality of life for Parkinson's patients.
Parkinson's disease is a progressive neurological disorder characterized by tremors, muscle rigidity, bradykinesia, and postural instability. It is more common in older adults, affecting 1% of those over 65 and 5% over 80. The cause is unknown but likely involves genetic and environmental factors. Diagnosis is based on symptoms and examination findings, and management focuses on medications to increase dopamine levels like levodopa as well as exercises, diet, and potential surgical interventions like deep brain stimulation. Nursing care aims to promote mobility, nutrition, communication and prevent complications through exercises and self-care education.
Parkinson’s disease detection system using Support vector machineIRJET Journal
This document summarizes a research paper on developing a Parkinson's disease detection system using support vector machines (SVM). The researchers collected vocal data from patients and trained an SVM model to classify Parkinson's disease based on vocal features. They preprocessed the data, split it into training and test sets, and trained the SVM model. The model achieved accurate detection of Parkinson's disease on both the training and test sets. In the future, the researchers aim to improve the system by connecting it to microphones to allow direct user input and linking users to doctors. The system is intended to help detect Parkinson's disease earlier.
Parkinsonism is a clinical syndrome characterized by motor symptoms like bradykinesia, tremor, and rigidity. It has multiple causes including Parkinson's disease, which is the most common form. Parkinson's disease is a neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra. The motor symptoms are diagnosed based on the presence of two of the four cardinal features - bradykinesia, tremor, rigidity, and postural instability. There is no cure for Parkinsonism currently, so treatment focuses on relieving the motor symptoms and managing non-motor issues.
Parkinsonism is a clinical syndrome characterized by motor symptoms like bradykinesia, tremor, and rigidity. It has multiple causes including Parkinson's disease, which is the most common form. Parkinson's disease is a neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra. The motor symptoms are diagnosed based on the presence of two of the four cardinal features - bradykinesia, tremor, rigidity, and postural instability. Non-motor symptoms are also common. While there is no cure for Parkinson's disease, treatment aims to manage the motor symptoms and other associated issues through medications and other therapies.
This document discusses chronic diseases and proposes a framework for early detection. It begins by defining chronic diseases and listing some common types like arthritis, cancer, stroke, and heart attack. Parkinson's disease is then discussed in more detail, including its causes, symptoms, increasing rates, and challenges around early detection. The importance of early detection for Parkinson's is explained. Recent research on potential biomarkers from cerebrospinal fluid and blood is mentioned. Research from India and abroad is summarized, including studies using smartphones to assess tremors, deep learning to analyze sensor data, and quantifying finger tremors. The document concludes by emphasizing the need for more research to enable earlier detection of Parkinson's disease.
This document discusses using machine learning algorithms to classify Parkinson's disease and compare parametric and nonparametric models. It analyzes a Parkinson's disease dataset using logistic regression as the parametric model and random forest and k-means algorithms as nonparametric models. The accuracy of each model is evaluated to determine which performs best at classifying the training and test data. Both motor and non-motor Parkinson's symptoms are considered. Three performance metrics - accuracy, sensitivity, and specificity - are used to evaluate the machine learning algorithms and models.
This document provides an overview of Parkinson's disease, including its symptoms, stages of progression, causes, risk factors, diagnosis, and treatment options. Parkinson's is a progressive neurological disorder that results from the loss of dopamine-producing cells in the brain. Its primary symptoms are tremors, rigidity, bradykinesia, and postural instability. While there is no cure, treatments can help manage symptoms and maintain quality of life, such as medication to increase dopamine levels, surgery, physiotherapy, and deep brain stimulation.
This document is a handbook for Parkinson's disease patients and their families that provides information about symptoms, causes, and treatments. It begins with an introduction to Parkinson's disease, describing it as a disorder of the central nervous system involving degeneration of neurons in the basal ganglia. The handbook then covers initial symptoms, primary symptoms such as tremor and rigidity, secondary symptoms, other types of parkinsonism, potential causes, and various treatment options. It aims to inform readers about Parkinson's disease while not substituting for medical advice.
Parkinson's disease is a progressive neurological disorder that results from the loss of dopamine-producing neurons in the brain. The main symptoms include tremors, rigidity, slow movement, and impaired balance and coordination. There is no cure for Parkinson's, but treatments can help manage the motor symptoms by replacing dopamine or mimicking its effects in the brain. Diet and nutrition also play an important role, as the disease can affect swallowing, digestion and weight. Maintaining a healthy diet with small, frequent meals and modifying protein intake is recommended. Exercise is also encouraged to help with symptoms and overall well-being. While Parkinson's is not fatal, complications from the disease are a leading cause of death.
Parkinsonism is an umbrella term for conditions that cause symptoms of slow movement, tremors, rigidity and problems walking. There are several forms of parkinsonism including Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, normal pressure hydrocephalus, vascular or arteriosclerotic parkinsonism, and drug-induced parkinsonism. Symptoms include bradykinesia, tremors, rigidity, impaired gait, and problems with speech, swallowing and constipation. Diagnosis is based on medical history and movement tests as there are no definitive tests. Treatment depends on the specific type but may include medications and lifestyle changes to stay active and modify the environment.
Module: Pharmacotherapy III
Module Coordinator: Dr. Arwa M. Amin Mostafa
Academic Level: Postgraduate, Master of Pharmacy in Clinical Pharmacy
School: Dubai Pharmacy College
Year of first presented in Class: 2018
This presentation is for Educational purpose. It has no commercial value associated with it.
Parkinson's disease is a brain disorder that progressively affects a person’s ability to control body movements, caused by a disorder of certain nerve cells in a part of the brain that produces dopamine, a chemical messenger the brain uses to help direct and control body movement.
Early diagnosis of Parkinson's disease gives you the best chance of a longer, healthier life. This presentation covers the information about biomarkers for Parkinson Diseases which include biological, physiological and imagine candidate / novel biomarkers.
This document reviews research on quantitatively assessing, detecting, and suppressing Parkinson's disease (PD) hand tremor. Several studies are discussed that use devices and sensors to measure grip force, wrist movement, and hand tremors in PD patients performing various motor tasks. Assessment results are often compared to standard PD rating scales. The goal of this research is to develop more objective, accurate methods of assessing PD severity and motor function to improve diagnosis and treatment.
'Parkinson's Disease Service in Cumbria' - Dr Jim George (Consultant Physician for North Cumbria University Trust) from the Cumbria Neuroscience Conference
Parkinson's disease is a degenerative disorder of the central nervous system that affects movement. It occurs when nerve cells in the brain do not produce enough dopamine. The document outlines the symptoms, stages, causes, treatment, and animal models of Parkinson's disease. The main symptoms are motor symptoms like tremors and rigidity as well as non-motor symptoms like mood changes. Treatment focuses on replacing dopamine and managing symptoms, primarily using levodopa and dopamine agonists. Animal models aim to reproduce the features of Parkinson's through pharmacological or genetic means to better understand and research the disease.
A SURVEY ON PARKINSON’S DISEASE DETECTION TECHNIQUESIRJET Journal
This document discusses techniques for detecting Parkinson's disease through analysis of voice recordings. It provides an overview of several machine learning and deep learning algorithms that have been applied to classify Parkinson's disease based on voice data, including artificial neural networks, random forest classifiers, convolutional neural networks and adaptive backpropagation neural networks. Accuracy rates between 85-88% were reported. The document also discusses the use of techniques like fuzzy C-means clustering and efficient randomized feature selection algorithms to improve Parkinson's disease detection from voice recordings.
This document discusses Parkinson's disease, including its definition, signs and symptoms, causes, pathophysiology, diagnosis, treatment, and nursing management. Parkinson's is a progressive nervous system disorder that causes movement issues like tremors and rigidity. It results from the loss of dopamine-producing neurons in the brain. While the exact cause is unknown, risk factors include age, genetics, and environmental toxins. Treatment focuses on increasing dopamine levels through medications or surgery. Nurses help manage symptoms, monitor for complications, and promote independence and safety.
In what daily activities do patients achieve independence after stroke 19 07-...Phinoj K Abraham
1) The study examined improvements in individual activities of daily living (ADLs) after stroke rehabilitation and identified prognostic factors.
2) It found the highest recovery for bowel/bladder function and mobility, and lowest for bathing/dressing/grooming and stairs. Neglect was a negative prognostic factor for most ADLs.
3) Younger age, male gender, and absence of neglect predicted independence in 83% of ADLs, while neglect significantly impacted all ADLs except bowel function.
The document provides guidance on how to write a dissertation or thesis. It discusses establishing a writing routine, structuring the document with appropriate front matter, chapters, and end matter. Key chapters include an introduction outlining the research problem and significance, a literature review analyzing prior studies, a methodology chapter, and a discussion chapter interpreting the results. The document emphasizes writing in a clear, organized manner and properly citing references. It aims to help students understand the components of a dissertation and best practices for writing this academic document.
More Related Content
Similar to Occupational Therapy Management for Parkinson's Disease - Webinar 2024
Submission Ide 88c19114-7d71-4703-b679-22f6c2ee580479 SI.docxdavid4611
Submission Ide: 88c19114-7d71-4703-b679-22f6c2ee5804
79% SIMILARITY SCORE 4 CITATION ITEMS 66 GRAMMAR ISSUES 0 FEEDBACK COMMENT
Internet Source 79%
Institution 0%
Muhammad Aftkhar
Parkinsonism- Pharmaceutical Treatment Plan.docx
Summary
1140 Words
1
Running Header: PARKINSON'S DISEASE
2
PARKINSON'S DISEASE
Parkinson’s disease
Parkinson's disease is a neuro de-generative disease that occurs and depletes the neurons
present in substansia nigra. These neurons are involved in the transmission of nerve impulses
Web Content: https://mynursingexperts.com/checking-and-assignment-corection/…
Spelling mistake: neuro euro
Spelling mista...: de-generative degenerative
PARKINSON'S DISEASE
MUHAMMAD AFTKHAR
NUR 635 (GCU)
Mar 4th, 2020
https://www.researchgate.net/profile/Charles_Davie/publication/5454757_A_review_of_Parkinson's_disease/links/5866522a08ae8fce490ee2e6/A-review-of-Parkinsons-disease.pdf
https://www.researchgate.net/profile/Charles_Davie/publication/5454757_A_review_of_Parkinson's_disease/links/5866522a08ae8fce490ee2e6/A-review-of-Parkinsons-disease.pdf
https://www.sciencedirect.com/science/article/abs/pii/S1474442218302394
https://www.sciencedirect.com/science/article/abs/pii/S1043661818321078
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140171/
from corpus collosum to the susbtansia nigra part of the mid brain. These are the character
playing neurons in managing voluntary motor movements in the body. It mostly occurs in elderly
patients describe by involuntary movements and multi-dimensional brain functioning. The part
of this disease may occur due to the effective and excessive use of medications indulging in bi
polar or Alzheimer's disease (Davie, 2008). The decline of dopamine in par compacta
deteriorates the normal functioning of the brain in controlling motor activities.
Prescription medication
The prescribed medications used for Parkinson’s disease includes the use of Levodopa
directly with replenishes the pool for dopamine neurotransmitter. This drug can’t be given in a
single dose rather without carbidopa (LODOSYN) the levodopa will break down into dopamine
and then to epinephrine in the body’s periphery. This will create severe symptomatic side effects
like an increase in heart rate and sympathetic system dominancy. Dopa-decarboxylase enzyme
breaks down the levodopa in the periphery so along with levodopa carbidopa is given. This
inhibits the dopa-decarboxylase enzyme and allows levodopa to travel into the blood brain
barrier easily.
For the calculations of drug regimen there must be precautionary measures for kidney
and liver sensitive enzyme dependent patients. LFT and RFT’s for sensitive patients are done to
ensure the correct for dose adjustments not lying in range affecting kidneys and liver function.
Below are some of the medications for Parkinson’s d.
This document proposes a randomized controlled study to investigate the effects of bright light therapy on sleep and mood disorders in Parkinson's disease. 80 Parkinson's patients will be included and randomized to either real or placebo light therapy groups. Primary outcomes will be mood measures, and sleep parameters, motor symptoms, physiological markers, and biological rhythms will also be assessed if additional funding is obtained. The goal is to develop an effective non-pharmacological therapy to improve sleep, mood, and quality of life for Parkinson's patients.
Parkinson's disease is a progressive neurological disorder characterized by tremors, muscle rigidity, bradykinesia, and postural instability. It is more common in older adults, affecting 1% of those over 65 and 5% over 80. The cause is unknown but likely involves genetic and environmental factors. Diagnosis is based on symptoms and examination findings, and management focuses on medications to increase dopamine levels like levodopa as well as exercises, diet, and potential surgical interventions like deep brain stimulation. Nursing care aims to promote mobility, nutrition, communication and prevent complications through exercises and self-care education.
Parkinson’s disease detection system using Support vector machineIRJET Journal
This document summarizes a research paper on developing a Parkinson's disease detection system using support vector machines (SVM). The researchers collected vocal data from patients and trained an SVM model to classify Parkinson's disease based on vocal features. They preprocessed the data, split it into training and test sets, and trained the SVM model. The model achieved accurate detection of Parkinson's disease on both the training and test sets. In the future, the researchers aim to improve the system by connecting it to microphones to allow direct user input and linking users to doctors. The system is intended to help detect Parkinson's disease earlier.
Parkinsonism is a clinical syndrome characterized by motor symptoms like bradykinesia, tremor, and rigidity. It has multiple causes including Parkinson's disease, which is the most common form. Parkinson's disease is a neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra. The motor symptoms are diagnosed based on the presence of two of the four cardinal features - bradykinesia, tremor, rigidity, and postural instability. There is no cure for Parkinsonism currently, so treatment focuses on relieving the motor symptoms and managing non-motor issues.
Parkinsonism is a clinical syndrome characterized by motor symptoms like bradykinesia, tremor, and rigidity. It has multiple causes including Parkinson's disease, which is the most common form. Parkinson's disease is a neurodegenerative disorder caused by the loss of dopamine-producing neurons in the substantia nigra. The motor symptoms are diagnosed based on the presence of two of the four cardinal features - bradykinesia, tremor, rigidity, and postural instability. Non-motor symptoms are also common. While there is no cure for Parkinson's disease, treatment aims to manage the motor symptoms and other associated issues through medications and other therapies.
This document discusses chronic diseases and proposes a framework for early detection. It begins by defining chronic diseases and listing some common types like arthritis, cancer, stroke, and heart attack. Parkinson's disease is then discussed in more detail, including its causes, symptoms, increasing rates, and challenges around early detection. The importance of early detection for Parkinson's is explained. Recent research on potential biomarkers from cerebrospinal fluid and blood is mentioned. Research from India and abroad is summarized, including studies using smartphones to assess tremors, deep learning to analyze sensor data, and quantifying finger tremors. The document concludes by emphasizing the need for more research to enable earlier detection of Parkinson's disease.
This document discusses using machine learning algorithms to classify Parkinson's disease and compare parametric and nonparametric models. It analyzes a Parkinson's disease dataset using logistic regression as the parametric model and random forest and k-means algorithms as nonparametric models. The accuracy of each model is evaluated to determine which performs best at classifying the training and test data. Both motor and non-motor Parkinson's symptoms are considered. Three performance metrics - accuracy, sensitivity, and specificity - are used to evaluate the machine learning algorithms and models.
This document provides an overview of Parkinson's disease, including its symptoms, stages of progression, causes, risk factors, diagnosis, and treatment options. Parkinson's is a progressive neurological disorder that results from the loss of dopamine-producing cells in the brain. Its primary symptoms are tremors, rigidity, bradykinesia, and postural instability. While there is no cure, treatments can help manage symptoms and maintain quality of life, such as medication to increase dopamine levels, surgery, physiotherapy, and deep brain stimulation.
This document is a handbook for Parkinson's disease patients and their families that provides information about symptoms, causes, and treatments. It begins with an introduction to Parkinson's disease, describing it as a disorder of the central nervous system involving degeneration of neurons in the basal ganglia. The handbook then covers initial symptoms, primary symptoms such as tremor and rigidity, secondary symptoms, other types of parkinsonism, potential causes, and various treatment options. It aims to inform readers about Parkinson's disease while not substituting for medical advice.
Parkinson's disease is a progressive neurological disorder that results from the loss of dopamine-producing neurons in the brain. The main symptoms include tremors, rigidity, slow movement, and impaired balance and coordination. There is no cure for Parkinson's, but treatments can help manage the motor symptoms by replacing dopamine or mimicking its effects in the brain. Diet and nutrition also play an important role, as the disease can affect swallowing, digestion and weight. Maintaining a healthy diet with small, frequent meals and modifying protein intake is recommended. Exercise is also encouraged to help with symptoms and overall well-being. While Parkinson's is not fatal, complications from the disease are a leading cause of death.
Parkinsonism is an umbrella term for conditions that cause symptoms of slow movement, tremors, rigidity and problems walking. There are several forms of parkinsonism including Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, normal pressure hydrocephalus, vascular or arteriosclerotic parkinsonism, and drug-induced parkinsonism. Symptoms include bradykinesia, tremors, rigidity, impaired gait, and problems with speech, swallowing and constipation. Diagnosis is based on medical history and movement tests as there are no definitive tests. Treatment depends on the specific type but may include medications and lifestyle changes to stay active and modify the environment.
Module: Pharmacotherapy III
Module Coordinator: Dr. Arwa M. Amin Mostafa
Academic Level: Postgraduate, Master of Pharmacy in Clinical Pharmacy
School: Dubai Pharmacy College
Year of first presented in Class: 2018
This presentation is for Educational purpose. It has no commercial value associated with it.
Parkinson's disease is a brain disorder that progressively affects a person’s ability to control body movements, caused by a disorder of certain nerve cells in a part of the brain that produces dopamine, a chemical messenger the brain uses to help direct and control body movement.
Early diagnosis of Parkinson's disease gives you the best chance of a longer, healthier life. This presentation covers the information about biomarkers for Parkinson Diseases which include biological, physiological and imagine candidate / novel biomarkers.
This document reviews research on quantitatively assessing, detecting, and suppressing Parkinson's disease (PD) hand tremor. Several studies are discussed that use devices and sensors to measure grip force, wrist movement, and hand tremors in PD patients performing various motor tasks. Assessment results are often compared to standard PD rating scales. The goal of this research is to develop more objective, accurate methods of assessing PD severity and motor function to improve diagnosis and treatment.
'Parkinson's Disease Service in Cumbria' - Dr Jim George (Consultant Physician for North Cumbria University Trust) from the Cumbria Neuroscience Conference
Parkinson's disease is a degenerative disorder of the central nervous system that affects movement. It occurs when nerve cells in the brain do not produce enough dopamine. The document outlines the symptoms, stages, causes, treatment, and animal models of Parkinson's disease. The main symptoms are motor symptoms like tremors and rigidity as well as non-motor symptoms like mood changes. Treatment focuses on replacing dopamine and managing symptoms, primarily using levodopa and dopamine agonists. Animal models aim to reproduce the features of Parkinson's through pharmacological or genetic means to better understand and research the disease.
A SURVEY ON PARKINSON’S DISEASE DETECTION TECHNIQUESIRJET Journal
This document discusses techniques for detecting Parkinson's disease through analysis of voice recordings. It provides an overview of several machine learning and deep learning algorithms that have been applied to classify Parkinson's disease based on voice data, including artificial neural networks, random forest classifiers, convolutional neural networks and adaptive backpropagation neural networks. Accuracy rates between 85-88% were reported. The document also discusses the use of techniques like fuzzy C-means clustering and efficient randomized feature selection algorithms to improve Parkinson's disease detection from voice recordings.
This document discusses Parkinson's disease, including its definition, signs and symptoms, causes, pathophysiology, diagnosis, treatment, and nursing management. Parkinson's is a progressive nervous system disorder that causes movement issues like tremors and rigidity. It results from the loss of dopamine-producing neurons in the brain. While the exact cause is unknown, risk factors include age, genetics, and environmental toxins. Treatment focuses on increasing dopamine levels through medications or surgery. Nurses help manage symptoms, monitor for complications, and promote independence and safety.
Similar to Occupational Therapy Management for Parkinson's Disease - Webinar 2024 (20)
In what daily activities do patients achieve independence after stroke 19 07-...Phinoj K Abraham
1) The study examined improvements in individual activities of daily living (ADLs) after stroke rehabilitation and identified prognostic factors.
2) It found the highest recovery for bowel/bladder function and mobility, and lowest for bathing/dressing/grooming and stairs. Neglect was a negative prognostic factor for most ADLs.
3) Younger age, male gender, and absence of neglect predicted independence in 83% of ADLs, while neglect significantly impacted all ADLs except bowel function.
The document provides guidance on how to write a dissertation or thesis. It discusses establishing a writing routine, structuring the document with appropriate front matter, chapters, and end matter. Key chapters include an introduction outlining the research problem and significance, a literature review analyzing prior studies, a methodology chapter, and a discussion chapter interpreting the results. The document emphasizes writing in a clear, organized manner and properly citing references. It aims to help students understand the components of a dissertation and best practices for writing this academic document.
Does Postural Stability Affect the Performance of eye Hand coordination in St...Phinoj K Abraham
This study examined eye-hand coordination and postural stability in 15 community-dwelling stroke survivors. It found that stroke survivors had slower reaction times and longer movement times when performing a finger pointing task with their paretic arm, especially when standing. Total sway and anterior-posterior displacement also increased when pointing with the paretic arm while standing. There were correlations between better eye-hand coordination and greater muscle strength, functional reach, and balance. The findings suggest that rehabilitation should train eye-hand coordination in both sitting and standing postures and address balance to improve upper limb function during daily activities.
1) The document discusses current evidence on understanding and managing the hemiplegic shoulder.
2) It finds that proper positioning helps avoid subluxation but slings and strapping do not reduce subluxation or improve function. Gentle range of motion exercises are preferred.
3) Electrical stimulation prevents subluxation development while hand edema can be treated with passive motion or electrical stimulation.
This document discusses the mirror neuron system and its role in neurorehabilitation. It begins by providing an overview of mirror neurons, their role in imitation and action understanding. It then discusses how the mirror neuron system can be used in neurorehabilitation approaches like motor imagery, mirror therapy, and action observation. While these mirror neuron-based interventions provide additional methods for motor training and recovery from stroke, there are also potential challenges to their use including damaged brain areas limiting activation and issues with patient fatigue or attention.
Post Stroke Upper Extremity Rehabilitation - A Clinical PerspectivePhinoj K Abraham
Guest Speak at 3rd Annual national conference of Indian Federation of Neurorehabilitation (IFNRCON 2015) at Mumbai by Phinoj K. Abraham, Neuro Occupational Therapy on "Post Stroke Upper Extremity rehabilitation - A Clinical Perspective"
For Video: http://youtu.be/uCnwdzLtPSQ
This presentation was prepared for educating the patients with stroke and their caregivers about the role of Occupational Therapy in Parkinson's Disease. It gives a very BRIEF over view about OT in Parkinson's Disease rehabilitation
BOT New Modified Syllabus & Regulations_TN Dr. MGR Medical Universisty, Chenn...Phinoj K Abraham
Finally find out today...!!
Dear all,
Herewith I am attaching our 'BOT syllabus' (Full, neat copy..!!) (TN Dr. MGR Medical University_New Modified Regulations & Syllabus (Semester) Bachelor of Occupational Therapy (B.O.T)) I hope this may be helpful for some of us during various academic credential evaluation..!!
This presentation was prepared for educating the patients with stroke and their caregivers about the role of Occupational Therapy in stroke. It gives a very BRIEF over view about OT in stroke rehabilitation
This document discusses dysphagia (difficulty swallowing) in pseudobulbar palsy. It begins by defining bulbar palsy and pseudobulbar palsy, noting that bulbar palsy involves lower motor neuron lesions affecting bulbar muscles, while pseudobulbar palsy involves upper motor neuron lesions. It then describes the anatomy and physiology of swallowing, including the four phases. It discusses the causes, signs, and treatments of dysphagia. Key assessment tools mentioned include a video swallow study and 3-ounce water swallow test. The document provides an overview of dysphagia for health professionals.
This document provides an overview of balance, including definitions, components, and assessment strategies. It defines balance as controlling the center of gravity over the base of support. The major sections discuss the sensory, central processing, and effector systems involved in balance, as well as age-related changes. Assessment strategies examined include self-report measures, clinical balance tests under various sensory conditions, and functional scales to evaluate mobility and gait. Comprehensive assessment involves testing balance under different contexts to evaluate the underlying sensory, motor, and cognitive systems.
Occupational Therapy management for Post polio syndromePhinoj K Abraham
This document discusses post-polio syndrome (PPS), including its definition, epidemiology, causes, clinical features, management, and prognosis. PPS is characterized by new symptoms that emerge decades after an initial bout of paralytic polio, including fatigue, muscle weakness, pain, and loss of function. While the exact pathophysiology is unknown, it is thought to involve the overuse and aging of motor neurons damaged during the initial polio infection. Management focuses on rehabilitation, medication for symptoms, lifestyle modifications, and assistive devices. Prognosis is generally good with treatment, though severe pulmonary or swallowing involvement can be life-threatening in rare cases.
This presentation is primarily based on an article Titled "Rehabilitation of Unilateral Spatial Neglect: New Insights from Magnetic Resonance Perfusion Imaging" by Argye E Hillis., Arch Phys Med Rehabil 2006;87(12 Suppl 2):S43-9.
Aim of this presenattaion was to give an insight to my students about Rehabilitation of Unilateral Spatial neglect
At Malayali Kerala Spa Ajman we providing the top quality massage services for our customers.
Our massage center prioritizes efficiency to ensure a quality massage experience for our clients at Malayali Kerala Spa Ajman. We offer a convenient appointment system and precise massage services.
Reach us at Villa No 7, Near Ammar Bin Yasir Street Al Rashidiya 2 - Ajman - United Arab Emirates.
Phone : +971 529818279
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
The Ultimate Guide in Setting Up Market Research System in Health-TechGokul Rangarajan
How to effectively start market research in the health tech industry by defining objectives, crafting problem statements, selecting methods, identifying data collection sources, and setting clear timelines. This guide covers all the preliminary steps needed to lay a strong foundation for your research.
"Market Research it too text-booky, I am in the market for a decade, I am living research book" this is what the founder I met on the event claimed, few of my colleagues rolled their eyes. Its true that one cannot over look the real life experience, but one cannot out beat structured gold mine of market research.
Many 0 to 1 startup founders often overlook market research, but this critical step can make or break a venture, especially in health tech.
But Why do they skip it?
Limited resources—time, money, and manpower—are common culprits.
"In fact, a survey by CB Insights found that 42% of startups fail due to no market need, which is like building a spaceship to Mars only to realise you forgot the fuel."
Sudharsan Srinivasan
Operational Partner Pitchworks VC Studio
Overconfidence in their product’s success leads founders to assume it will naturally find its market, especially in health tech where patient needs, entire system issues and regulatory requirements are as complex as trying to perform brain surgery with a butter knife. Additionally, the pressure to launch quickly and the belief in their own intuition further contribute to this oversight. Yet, thorough market research in health tech could be the key to transforming a startup's vision into a life-saving reality, instead of a medical mishap waiting to happen.
Example of Market Research working
Innovaccer, founded by Abhinav Shashank in 2014, focuses on improving healthcare delivery through data-driven insights and interoperability solutions. Before launching their platform, Innovaccer conducted extensive market research to understand the challenges faced by healthcare organizations and the potential for innovation in healthcare IT.
Identifying Pain Points: Innovaccer surveyed healthcare providers to understand their difficulties with data integration, care coordination, and patient engagement. They found widespread frustration with siloed systems and inefficient workflows.
Competitive Analysis: Analyzed competitors offering similar solutions in healthcare analytics and interoperability. Identified gaps in comprehensive data aggregation, real-time analytics, and actionable insights.
Regulatory Compliance: Ensured their platform complied with HIPAA and other healthcare data privacy regulations. This compliance was crucial to gaining trust from healthcare providers wary of data security issues.
Customer Validation: Conducted pilot programs with several healthcare organizations to validate the platform's effectiveness in improving care outcomes and operational efficiency. Gathered feedback to refine features and user interface.
Nursing management of the patient with Tonsillitis PPTblessyjannu21
Prepared by Prof. Blessy Thomas MSc Nursing, FNCON, SPN. The tonsils are two small glands that sit on either side of the throat.
In young children, they help to fight germs and act as a barrier against infection.
Tonsils act as filters, trapping germs that could otherwise enter the airways and cause infection.
They also make antibodies to fight infection.
But sometimes, they get overwhelmed by bacteria or viruses.
This can make them swollen and inflamed.
Tonsillitis is an infection of the tonsils, two masses of tissue at the back of the throat.
Tonsillitis is inflammation of the tonsils, two oval-shaped pads of tissue at the back of the throat — one tonsil on each side.
Tonsillitis is common, especially in children.
It can happen once in a while or come back again and again in a short period.Nursing management of Tonsillitis is important.
A comprehensive understanding of the operations for management of Tonsillitis and areas requiring special attention would be important.
Cancer treatment has advanced significantly over the years, offering patients various options tailored to their specific type of cancer and stage of disease. Understanding the different types of cancer treatments can help patients make informed decisions about their care. In this ppt, we have listed most common forms of cancer treatment available today.
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...Media Logic
When it comes to creating marketing strategies that target older adults, it is crucial to have insight into their media habits and preferences. Understanding how older adults consume and use media is key to creating acquisition and retention strategies. We recently conducted our seventh annual survey to gain insight into the media preferences of older adults in 2024. Here are the survey responses and marketing implications that stood out to us.
Exploring Stem Cell Solutions for Parkinson's Disease with Dr. David Greene A...Dr. David Greene Arizona
Dr. David Greene of Arizona is at the forefront of stem cell therapy for Parkinson's Disease, focusing on innovative treatments to restore dopamine-producing neurons. His research explores the use of embryonic stem cells, induced pluripotent stem cells, and adult stem cells to replace lost neurons and potentially reverse disease progression. By transplanting differentiated cells into affected brain areas, Dr. Greene aims to address the root cause of Parkinson's. His work also investigates the neuroprotective benefits of stem cells, offering hope for effective, long-term treatments. Discover how Dr. Greene's pioneering efforts could transform Parkinson's Disease therapy.
Malayali Kerala Spa in Ajman, one among the top rated massage centre in ajman, welcomes you to experience high quality massage services from massage staffs from all ove rthe world! Being the best spa massage service providers, we take pride in offering traditional massage services of different countries, like
Indian Massage, Kerala Massage, Thai Massage, Pakistani Massage, Russian Massage etc
If you are seeking relaxation, pain relief, or wellness experience, our ajman spa is here for your unique needs and concerns. The services of our experienced therapists, and personalized attention will ensure that each visit will be memorable for you.
Book your appointment today and let us take you to a world of serenity and self-care. Because you deserves the best.
3. • Deane KHO, Ellis-Hill C, Dekker K, Davies P, Clarke CE. A Survey of Current Occupational Therapy Practice for Parkinson’s Disease in the United Kingdom. British Journal of Occupational Therapy.
2003;66(5):193-200. doi:10.1177/030802260306600503
• Deane KHO, Ellis-Hill C, Dekker K, Davies P, Clarke CE. A Delphi Survey of Best Practice Occupational Therapy for Parkinson’s Disease in the United Kingdom. British Journal of Occupational Therapy.
2003;66(6):247-254. doi:10.1177/030802260306600603 3
4. The survey demonstrated that:
1. OTs emphasized self-care over Occupational Performance
2. OTs lacked knowledge in condition-specific interventions for PD and
3. OTs expressed a need for more training to address occupational performance
aspects of Parkinson's care
4
5. The Gap..
We as OT’s,
sometimes miss out to fully address Occupational Performance,
which is the core part of Occupational Therapy
5
6. Objectives
• Identify the impact of Parkinson's disease on a client's occupational performance
and quality of life.
• Analyze a framework for occupational therapy intervention in Parkinson's disease
that addresses all aspects of Occupational Performance.
• Explore evidence-based occupational therapy interventions for managing
Parkinson's disease symptoms.
6
9. Parkinson’s Disease
• …is a progressive, neurodegenerative disorder that affects
predominately the dopamine-producing (“dopaminergic”) neurons in
substantia nigra (basal ganglia), characterized by the onset of tremor,
muscle rigidity, slowness in movement (bradykinesia), and
stooped posture (postural instability).
What is Parkinson’s? (n.d.). Parkinson’s Foundation. https://www.parkinson.org/understanding-parkinsons/what-is-parkinsons
9
10. Symptoms of PD
Motor Symptoms
Bradykinesia - Movement starts
but is slow
Hypokinesia - Movement starts but
is small
Akinesia - inability to initiate
movement
Rigidity
Rest tremor
Postural instability
Non-motor Symptoms
Cognitive Dysfunctions
Emotional and neuropsychiatric
problems
Autonomic failure - sweating
Incontinence
Sexual health issues
Fatigue
Pain
Sleep disturbance
Dementia
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
10
11. Symptoms of PD
Motor Symptoms
Akinesia - inability to initiate
movement
Bradykinesia - Movement starts
but is slow
Hypokinesia - Movement starts but
is small
Rigidity
Rest tremor
Postural instability
Non-motor Symptoms
Autonomic failure - sweating
Incontinence
Sexual health issues
Fatigue
Pain
Sleep disturbance
Cognitive Dysfunctions
Emotional and neuropsychiatric
problems
Dementia
Cincotta, M. C. (2023, May 19). Newly Diagnosed With Parkinson’s Disease? Here’s What You Need to Know. Temple Health. https://www.templehealth.org/about/blog/understanding-
stages-of-parkinsons-disease 11
12. Prevalence and incidence of PD
• Parkinson's disease affects over 10 million people worldwide, with nearly 1 million in the
U.S. and expected to rise to 1.2 million by 2030.
• Incidence of PD has increased by 50%, with around 90,000 new diagnoses annually in the
U.S.
• Men have a 1.5 times higher incidence and prevalence of PD compared to women, with
prevalence increasing with age.
• In summary, Parkinson's disease is a growing public health concern, with hundreds
of thousands of new diagnoses each year in the U.S. alone.
Statistics (n.d.). Parkinson’s Foundation. https://www.parkinson.org/understanding-parkinsons/statistics
Prevalence & Incidence (n.d) Parkinson’s Foundation. https://www.parkinson.org/understanding-parkinsons/statistics/prevalence-incidence
12
13. Quick Facts
Parkinson's disease (PD) is the most common cause of parkinsonism (about 80%)
Risk Factors: Age, Genetics, Gender & Environmental Factors
PD remains incurable but treatable.
The disease progresses in stages, with symptoms gradually worsening over time.
The disease causes not only motor symptoms, but also cognitive, emotional and
other symptoms impacting quality of life
PD is often accompanied by social stigma and discrimination.
Shrimanker, I., Tadi, P., & Sánchez-Manso, J. C. (2022, June 7). Parkinsonism. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK542224/
Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., & Obeso, J. A. (2009). Initial clinical manifestations of Parkinson's disease: features and pathophysiological
mechanisms. The Lancet. Neurology, 8(12), 1128–1139. https://doi.org/10.1016/S1474-4422(09)70293-5 13
14. Parkinsonism Vs. Parkinson’s Disease
Parkinsonism
Primary
Parkinsonism
Parkinson’s
Disease
A Typical
Parkinsonism
(Parkinson+)
Secondary
Parkinsonism
Drug Induced
Parkinsonism
Vascular
Parkinsonism
& more..
References:
• Types of Parkinsonisms. (n.d.). Parkinson’s Foundation. https://www.parkinson.org/understanding-parkinsons/what-is-parkinsons/types-parkinsonisms
• What is Primary and Secondary Parkinsonism. WORLD PARKINSON’S PROGRAM. https://pdprogram.org/primary-and-secondary-parkinsonism/
14
15. Pathophysiology
Pathogenesis of PD remains unclear. Degeneration of dopamine-producing neurons in the
basal ganglia is believed to result in PD
Basal ganglia (‘autopilot’) - controls well-learnt voluntary and semi-automatic motor skills
and movements.
Dopamine is a major neurochemical messenger that promotes the functions of basal
ganglia.
Dopamine also contributes to other cognitive processes, such as attention, drive and
motivation, mood, problem-solving, decision-making, visual perception etc.
Dopamine deficiency in PD disrupts basal ganglia function, leading to PDD symptoms
Rouaud, T., Corbillé, A. G., Leclair-Visonneau, L., de Guilhem de Lataillade, A., Lionnet, A., Preterre, C., Damier, P., & Derkinderen, P. (2021). Pathophysiology of Parkinson's disease: Mitochondria, alpha-
synuclein and much more…. Revue neurologique, 177(3), 260–271. https://doi.org/10.1016/j.neurol.2020.07.016
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
15
16. Pathophysiology
Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., & Obeso, J. A. (2009). Initial clinical manifestations of Parkinson's disease: features and
pathophysiological mechanisms. The Lancet. Neurology, 8(12), 1128–1139. https://doi.org/10.1016/S1474-4422(09)70293-5 16
17. Stages of PD (Hoehn and Yahr Staging System)
Stage 1: Early stage
Mild motor symptoms, such as tremors unilaterally. Symptoms do not affect daily life
Stages 2: Early to Mid stage
More noticeable motor symptoms bilaterally. Daily activities become time consuming due to
difficulty in balance posture and walking. However, the person will be independent in daily
activities
Stage 3: Mid-Stage
Increased risk of falls due to balance problems, ADL can become challenging, However, the person
can still be independent in daily activities.
Stages 4: Late stage
Assistance required for ambulation. Dysphagia may be present. Full-time help may be required
Stage 5: Late Stage
Requires use of a wheelchair or is bedridden. Constant nursing care is necessary. Cognitive and
neuro psychiatric symptoms may also be present
Modestino EJ, Reinhofer A, Blum K, et al. Hoehn and Yahr staging of Parkinson's disease in relation to neuropsychological measures. Front Biosci (Landmark Ed). 2018;23(7):1370-1379. doi:10.2741/4649
Greco, P. (2023, April 26). What Are the Stages of Parkinson's Disease? Health. https://www.health.com/condition/parkinsons-disease/parkinsons-disease-stages
Stages of Parkinson’s. (n.d.). Parkinson’s Foundation. https://www.parkinson.org/understanding-parkinsons/what-is-parkinsons/stages
17
Note:
‘Early, Mid & late
stage’
terminology is
not part of this
classification
18. Hoehn and Yahr staging system based solely on observable motor symptoms.
Pre-Motor Stage of Parkinson's Disease occurs before diagnosis od PD and motor
symptoms.
May include:
Loss of sense of smell
REM sleep behavior disorder (acting out dreams)
Constipation
1) Reichmann H. Premotor diagnosis of Parkinson's disease. Neurosci Bull. 2017;33(5):526-534. doi:10.1007/s12264-017-0159-5
Greco, P. (2023, April 26). What Are the Stages of Parkinson's Disease? Health. https://www.health.com/condition/parkinsons-disease/parkinsons-disease-stages 18
Hoehn and Yahr Staging System & Premotor Stage of PD
19. Medical Management of PD
Medications
Levodopa
first-line drug
Often given in combination with the drug
carbidopa to reduce nausea
‘ON’ and ‘OFF’ times
Dopamine Agonist
Amantadine
Adenosine A2A antagonist
Anticholinergic Drugs
Surgery
• Deep Brain Stimulation
• mostly addresses the movement
symptoms – tremor, dyskinesia etc.
• benefits lasting at least five years.
• DUOPATM
• Intestinal gel of carbidopa-levodopa to
reduce “off” times
• Other Surgical options
• Thalamotomy
• Pallidotomy
• Sub thalamotomy
Treatment. (n.d.). Parkinson’s Foundation. https://www.parkinson.org/living-with-parkinsons/treatment 19
20. Section Summary
• Parkinson's disease (PD), the most common form of parkinsonism
affecting about 80% of cases, is a progressive and incurable but
treatable neurodegenerative disorder.
• Parkinson's disease (PD) goes beyond motor symptoms. It can also
affect cognition, emotions, and other areas of life, impacting quality of
life even before motor symptoms appear.
20
22. Jansa, J., & Aragon, A. (2015). Living with Parkinson's and the Emerging Role of Occupational Therapy. Parkinson's disease, 2015, 196303. https://doi.org/10.1155/2015/196303
Need of a conceptual framework
• A conceptual model provides broader structure to understand a concept.
• It can help OTs to:
• Holistic view of occupational performance: This considers the person, task, and environment.
• Plan intervention: Addresses impairment, activity limitations, and participation restrictions.
• Challenge: Occupational therapy's jargon-heavy conceptual models, create
communication barriers for other disciplines unfamiliar with the specific terminology.
• Solution: An interdisciplinary conceptual model, that can Facilitate communication and
collaboration between the OT’s, client, caregivers and other healthcare professionals.
22
23. Moradi, G., Gouya, M. M., Eshrati, B., Mohraz, M., & Piroozi, B. (2018). National action plan of the Islamic Republic of Iran for combating antimicrobial resistance during 2016 - 2021. Medical journal of the
Islamic Republic of Iran, 32, 65. https://doi.org/10.14196/mjiri.32.65
Haglund, L. and Henriksson, C. (2003), Concepts in occupational therapy in relation to the ICF. Occup. Ther. Int., 10: 253-268. https://doi.org/10.1002/oti.189
Hostettler, C., Hostettler, C., & Hostettler, C. (n.d.). ICF Case Studies - Introduction to the ICF. https://www.icf-casestudies.org/introduction/introduction-to-the-icf
ICF (International Classification of Functioning, Disability and Health)
ICF is a bio-psycho-social model of
functioning, disability and health by
WHO, outlines key component of health
& their relationship across different
context
23
Parkinson's disease (PD) affects people
differently, so OT’s need to consider each
person's unique situation. ICF helps in this.
24. Assessment tools
OTs select standardized and non standardized assessments that are relevant to the person's
goals and abilities. Some examples are;
• Disease Severity:
• Hoehn and Yahr Scale:
• Impairment Level:
• Unified Parkinson's Disease Rating Scale
(UPDRS)
• Movement Disorder Society-Unified
Parkinson's Disease Rating Scale (MDS-
UPDRS)
• Activity Limitations and Participation
Restrictions:
• Functional Independence Measure (FIM)
• Patient-Centered Occupational
Performance Measure (COPM)
• Quality of Life:
• Parkinson's Disease Questionnaire (PDQ-
39)
• Short Form-36 Health Survey (SF-36)
24
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
25. Impact of PD on Activity & Participation
1. Increased Stiffness and Reduced Trunk
Flexibility:
• Impacts: Difficulty turning, moving in bed,
performing daily activities (ADLs),
transferring, driving, socializing, and living
independently.
2. Gait and Balance Problems:
• Symptoms: Start hesitation, shuffling gait,
slowness, festination, freezing episodes,
postural instability.
• Impacts: Difficulty initiating walking,
increased risk of tripping, reduced walking
speed, impaired coordination during
turns, increased risk of falls.
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
25
26. Impact of PD on Activity & Participation
3. Reduced Manual Dexterity, Poor
Coordination, and Tremor:
• Impacts: Difficulty with daily tasks like eating,
dressing, applying makeup, and writing.
4. Dysarthria:
• Symptoms: Poor breath support, loss of voice
clarity, decreased speech intelligibility, reduced
volume.
• Impacts: Difficulty communicating effectively.
5 Fatigue:
• Impact: Reduced endurance for daily activities.
6. Cognitive Changes:
• Impacts: Slowed thinking (Bradyphrenia),
difficulty with problem-solving and decision-
making, reduced concentration, apathy leading
to social isolation, low mood, difficulty managing
roles at home, work, and socially.
Radder, D. L. M., Sturkenboom, I. H., van Nimwegen, M., Keus, S. H., Bloem, B. R., & de Vries, N. M. (2017). Physical therapy and occupational therapy in Parkinson’s disease. International Journal of
Neuroscience, 127(10), 930–943. https://doi.org/10.1080/00207454.2016.1275617
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
26
27. Impact of environmental & personal factors
Environmental Factors:
Home safety: Poorly lit areas, loose rugs, and
cluttered spaces can increase fall risk.
Accessibility: Difficulty navigating stairs, narrow
doorways, or a lack of grab bars can limit
mobility and independence.
Social settings: Noisy environments can worsen
communication difficulties.
Personal Factors:
Age: Symptoms often worsen with age.
Severity of disease: The degree of dopamine loss
impacts the severity of symptoms and limitations.
Cognitive status: Pre-existing cognitive decline can be
exacerbated by Parkinson's, further impacting daily
activities.
Motivation and coping skills: A person's outlook and
ability to adapt to limitations can significantly affect
their quality of life.
Radder, D. L. M., Sturkenboom, I. H., van Nimwegen, M., Keus, S. H., Bloem, B. R., & de Vries, N. M. (2017). Physical therapy and occupational therapy in Parkinson’s disease. International Journal of
Neuroscience, 127(10), 930–943. https://doi.org/10.1080/00207454.2016.1275617
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
27
28. Section Summary
• The ICF is a valuable conceptual model that OTs and other IDT professionals can
use to understand the impact of PD holistically and plan interventions
collaboratively.
• Suggested reading:
28
Radder, D. L. M., Sturkenboom, I. H., van Nimwegen, M., Keus, S. H., Bloem, B. R., & de Vries, N. M. (2017). Physical therapy and occupational therapy in Parkinson’s disease. International Journal
of Neuroscience, 127(10), 930–943. https://doi.org/10.1080/00207454.2016.1275617
30. The Role of Occupational Therapist…
‘The role of the occupational therapist is to support individuals with
Parkinson's disease and to enable them to maintain their usual level of
self‐care, work and leisure activities (Occupational Performance) for as
long as possible.’
Dixon, L., Duncan, D., Johnson, P., Kirkby, L., O'Connell, H., Taylor, H., & Deane, K. H. (2007). Occupational therapy for patients with Parkinson's disease. The Cochrane database of systematic
reviews, 2007(3), CD002813. https://doi.org/10.1002/14651858.CD002813.pub2
30
31. Principles of OT Interventions for PD
Early and Proactive Approach
Client-Centered and Evolving intervention
Holistic Focus and employment of a wide range of interventions
Collaborative Goal Setting with individual and carer, with regular
review.
Interdisciplinary Collaboration
31
1. What, when, how?
2. Is there any
guideline?
32. Aims & dose of therapy across the stages of PD
(What & When)
Early-stage PD Mid-stage PD Late-stage PD
Consultative,
Proactive Therapy
Restorative Therapy Skilled Maintenance
1-4 sessions with 6-12
month re-evaluation
2-4 visits/week
~1 visits every 1-3
months, ongoing
Stage of PD
Aim of
Therapy
Dose of
Therapy
Adopted from: Rafferty, M. R., Nettnin, E., Goldman, J. G., & MacDonald, J. (2021). Frameworks for Parkinson's Disease Rehabilitation Addressing When, What, and How. Current neurology and
neuroscience reports, 21(3), 12. https://doi.org/10.1007/s11910-021-01096-0
In addition to offering clinical guidance, this framework equips OTs with evidence-based reasoning for prescribing
optimal therapy frequencies for individuals with PD and explain this approach to stakeholders.
32
33. OT Interventions process (How?)
Jansa, J., & Aragon, A. (2015). Living with Parkinson's and the Emerging Role of Occupational Therapy. Parkinson's disease, 2015, 196303. https://doi.org/10.1155/2015/196303
(1) Enter/Initiate. (2) Set the stage.
(3)
Assess/evaluate.
(4) Agree
objective and
plans.
(5) Implement
plan.
(6)
Monitor/modify.
(7) Evaluate
outcome.
(8)
Conclude/exit.
33
34. Evidence based OT Interventions for PD
PD & OT: Past to Present
• Early 2000s: Limited research on specific OT
interventions for PD. Focus was on self-care and
daily activities.
• Today: More research supports OT's value in PD
rehab. Studies show positive results for
individual and group interventions.1, 2.
1. Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
2. Guidelines for Occupational Therapy in Parkinson’s Disease Rehabilitation by Dutch Association of Occupational Therapy 2011. Available at
https://www.parkinsonnet.nl/app/uploads/sites/3/2019/11/ot_guidelines_final-npf__3_.pdf
3. Jansa, J., & Aragon, A. (2015). Living with Parkinson's and the Emerging Role of Occupational Therapy. Parkinson's disease, 2015, 196303. https://doi.org/10.1155/2015/196303
34
35. Four Dimensions of OT Interventions
(Based on PD Guidelines)
1. Promoting Lifelong Well-being: Optimizes overall health, independence, and
quality of life for people with Parkinson's disease.
2. Empowering Movement: Develops strategies to improve initiation,
maintainability, and control of movement for daily activities.
3. Optimizing Activity Participation: Adapts tasks, environments, and routines to
maximize engagement in meaningful occupations.
4. Supporting End-of-Life Care: Provides comfort, dignity, and continued
participation in valued activities throughout the disease course.
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
35
36. 1. Promoting Lifelong Well-being
Key Areas of Focus for Occupational Therapists (OTs) are;
• Self-Efficacy & Resilience
• Roles & Relationships
• Sexual Well-being & Intimacy
• Work
• Social, Recreational & Leisure Activities
• Community Living Skills & Outdoor Mobility
How?
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational
Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons 36
37. 2. Empowering Movement
Key Principles for OT Interventions:
• Conscious Attention: Well-learned movements require focused attention for successful execution.
• Limiting Multitasking: Focus on practicing specific multitask activities instead of constant
multitasking.
• Cognitive & Sensory Cues: Utilize cues (visual, verbal, physical) to trigger and guide movement flow.
• Promote Mental well-being: through relaxation techniques, group programs or referral to mental
health services to enhance participation
Strategies for Initiating and Maintaining Movement
• Cueing
• Intrinsic Cues: self initiated cues like counting, self talk, visualization etc.
• Extrinsic Cues: External prompts like visual cues or verbal instructions to initiate movement.
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
37
38. 2. Empowering Movement
How does cueing works?
• Visual, auditory, or written cues draw attention to the desired movement goal,
encouraging patients to perform tasks less automatically and with more control
• Bypassing the underactive basal ganglia and activate alternative neural pathways, allowing
for better movement (i.e, ‘auto pilot system’ ‘Manual Control’) .
• Stimulating Neural Networks: Cues like visual guides or spoken instructions related to a
specific movement (e.g., “write bigger") can activate the brain networks responsible for
that action, leading to larger and more controlled movements (e.g., bigger handwriting)
Jansa, J., & Aragon, A. (2015). Living with Parkinson's and the Emerging Role of Occupational Therapy. Parkinson's disease, 2015, 196303. https://doi.org/10.1155/2015/196303
38
39. 2. Empowering Movement Cont.
Promoting New Learning:
• Timing: Conduct learning sessions when the person with PD is most alert ("on" state).
• Family/Carer Involvement: Educate and involve family/carers for better carry-over into daily life.
• Minimizing Distractions: Optimize focus during assessment and interventions.
• Instructional Techniques:
• Verbal instructions with key words.
• Visual demonstrations.
• Guided mental rehearsal.
• Hands-on guidance.
• Backward chaining approach (breaking down complex tasks).
• Cue cards for reminders.
• Encourage Self-talk: Promote internalization of key movement steps while performing actions.
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
39
40. 3. Optimizing Activity Participation
Aim: Improving participation in
meaningful occupations through:
• Adapting tasks and environments
• Modifying routines
• Utilizing assistive equipment
Key areas of focus:
Mobility
Falls Prevention
Transfers
Bed Mobility
Posture and Seating
Eating and Drinking
Self-Care
Domestic Skills
Fatigue Management
Handwriting and Communication
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
40
41. 4. Supporting End-of-Life Care
• Focus on Comfort and Quality of Life:
• Manage symptoms to maximize comfort
and dignity.
• Facilitate enjoyable activities (music,
spending time outdoors).
• Address complications of immobility
(positioning, pressure care).
• 24-Hour Posture and Positioning:
• Regularly assess posture in bed, chair,
wheelchair, car.
• Use pressure-relieving cushions and
mattresses.
• Consider splinting to prevent
contractures.
• Minimizing Manual Handling Risks:
• Assess risks for transfers and daily
activities.
• Provide appropriate equipment (lifts,
hoists) and training.
• Consider caregiver support and
limitations.
• Alternative Living Arrangements:
• Respect wishes for end-of-life care
• Discussing alternative living
arrangements like assisted living facilities
if staying home becomes difficult
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
41
42. Special Considerations..
‘The evidence based on specific
rehabilitation interventions is still very
scarce but should be considerably
improved in the next years.’
42
43. Section Summary
• Evidence supports OT's role in PD rehab:
• Growing research demonstrate the effectiveness of both individual and group interventions
delivered by occupational therapists.
• Addressing multifaced problem is a challenge
• Current OT practice may not always fully address the multifaceted challenges of PD through an
occupational performance-based approach.
• ICF can act as a ‘Holistic lens’
• The ICF framework provides a comprehensive understanding of how PD impacts individuals.
And it can enhance interdisciplinary collaboration
• Need of ‘client centered & Stage-specific care’
• A therapy framework considering the different stages of Parkinson's disease can guide the
development and delivery of targeted OT interventions specific to each patient's condition.
43
45. https://worldparkinsonsday.com/get-informed/
1. Ignite Innovation: Develop a comprehensive PD rehab program
addressing all aspects of occupational performance, tailored to your
local context.
2. Spark Collaboration: Formulate interdisciplinary clinics at your
workplace to offer holistic care for people with PD.
3. Fuel Connection: Foster support groups and peer counseling
interactions to empower social participation and well-being.
4. Share your ‘spark’: Share success stories through publications to inspire
others.
April 11
Share your
Spark &
Help people
with PD
around you
How?
45
47. Suggested Readings
• Pathophysiology of PD
• Rodriguez-Oroz, M. C., Jahanshahi, M., Krack, P., Litvan, I., Macias, R., Bezard, E., & Obeso, J. A. (2009). Initial clinical
manifestations of Parkinson's disease: features and pathophysiological mechanisms. The Lancet. Neurology, 8(12), 1128–1139.
https://doi.org/10.1016/S1474-4422(09)70293-5
• ICF (International Classification of Functioning, Disability and Health (ICF) by the World Health Assembly in May 2001)
• Hostettler, C., Hostettler, C., & Hostettler, C. (n.d.). ICF Case Studies - Introduction to the ICF. https://www.icf-
casestudies.org/introduction/introduction-to-the-icf
• OT Evaluation & Interventions
• Sadural, A., MacDonald, J., Johnson, J., Gohil, K., & Rafferty, M. (2022). Occupational Therapy for People with Early Parkinson's
Disease: A Retrospective Program Evaluation. Parkinson's disease, 2022, 1931468. https://doi.org/10.1155/2022/1931468
• Evidence based OT Intervention for PD
• Rafferty, M. R., Nettnin, E., Goldman, J. G., & MacDonald, J. (2021). Frameworks for Parkinson's Disease Rehabilitation
Addressing When, What, and How. Current neurology and neuroscience reports, 21(3), 12. https://doi.org/10.1007/s11910-
021-01096-0
• OT’s Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists
2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
• Jansa, J., & Aragon, A. (2015). Living with Parkinson's and the Emerging Role of Occupational Therapy. Parkinson's disease,
2015, 196303. https://doi.org/10.1155/2015/196303
47
48. Acknowledgement
Dr. Arun Kumar Malayappan, PhD, OT
Principal
Saveetha College of Occupational Therapy, Chennai.
44th Webinar on 12-04-2024
48
51. levels of OT interventions for progressive
movement disorders
• PD's variable symptoms and progression challenge OTs.
• Jeen et al.'s framework offers 3 levels of OT interventions for progressive
movement disorders, such as:
1. Skill Enhancement: Improve performance through physical techniques (e.g., transfers).
2. Knowledge Acquisition: Enhance performance with information on modifying tasks,
equipment, and resources.(e.g.
3. Attitude Adjustment: Adapt performance by modifying expectations and promoting
psychological well-being (e.g., using a scooter).
Jain S, Kings J, Playford ED. Occupational Therapy for People with Progressive Neurological Disorders: Unpacking the Black Box. British Journal of Occupational Therapy. 2005;68(3):125-130.
https://journals.sagepub.com/doi/10.1177/030802260506800305
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
51
52. levels of OT interventions for progressive
movement disorders
Jeen et al.'s framework
Jain S, Kings J, Playford ED. Occupational Therapy for People with Progressive Neurological Disorders: Unpacking the Black Box. British Journal of Occupational Therapy. 2005;68(3):125-130.
https://journals.sagepub.com/doi/10.1177/030802260506800305
Occupational therapy for people with Parkinson’s: best practice guidelines by Royal College of Occupational Therapists 2018. available at https://www.rcot.co.uk/occupational-therapy-people-parkinsons
52
Editor's Notes
The traditional definition, like the one above, only identifies the motor symptoms. However, in reality, PD comes with both motor and non motor symptoms and non-motor symptoms often appear before the motor symptoms in individuals with PD.
The traditional definition, like the one above, only identifies the motor symptoms. However, in reality, PD comes with both motor and non motor symptoms and non-motor symptoms often appear before the motor symptoms in individuals with PD.
Conceptual Framework: A conceptual framework provides a broader structure for understanding a concept. It outlines the key components, their relationships, and the overall principles involved. The ICF does this by offering a standardized language and a way to classify functioning, disability, and health across different contexts.
Conceptual Framework: A conceptual framework provides a broader structure for understanding a concept. It outlines the key components, their relationships, and the overall principles involved. The ICF does this by offering a standardized language and a way to classify functioning, disability, and health across different contexts.